Amgen Inc

Healthcare · Drug Manufacturers - General

414.60$ +2.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Amgen Inc (AMGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 10,054 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement AMGN
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	5,811	5,965	5,464	5,810	5,773	5,802	5,554	6,059	5,904	6,230	5,557	5,871	5,737	6,197	6,161	6,206	6,423	6,634	5,901	6,526	6,706	6,846	6,238	6,594	6,652	6,839	6,105	6,986	6,903	8,196	7,447	8,388	8,503	9,086	8,149	9,167	9,557	9,896	8,618	10,054	38,125
Cost of Revenue	1,027	1,067	996	1,024	990	1,059	944	1,024	1,037	1,096	1,055	1,012	1,036	1,253	1,513	1,488	1,561	1,597	1,490	1,637	1,609	1,718	1,561	1,510	1,588	1,747	1,720	1,813	1,806	3,112	3,200	3,236	3,310	3,112	2,968	3,011	3,082	1,790	2,744	2,811	10,427
Gross Profit	4,784	4,898	4,468	4,786	4,783	4,743	4,610	5,035	4,867	5,134	4,502	4,859	4,701	4,944	4,648	4,718	4,862	5,037	4,411	4,889	5,097	5,128	4,677	5,084	5,064	5,092	4,385	5,173	5,097	5,084	4,247	5,152	5,193	5,974	5,181	6,156	6,475	8,106	5,874	7,243	27,698
Research & Development	990	1,078	769	873	877	1,043	760	869	926	1,182	879	924	1,001	1,312	952	964	1,062	1,229	967	1,082	1,422	1,348	959	1,039	1,112	1,324	1,058	1,113	1,079	1,534	1,343	1,447	1,450	1,724	1,486	1,744	1,900	2,151	1,719	1,868	7,638
Selling, General & Administrative	1,244	892	1,064	1,209	1,170	875	1,127	1,353	1,293	885	1,154	1,260	1,223	724	1,316	1,295	1,346	811	1,315	1,384	1,305	582	1,228	1,327	1,287	731	1,258	1,294	1,353	1,627	1,808	1,785	1,625	891	1,687	1,691	1,720	1,952	1,602	1,745	7,019
Total Operating Expenses	2,257	2,413	1,877	2,088	2,344	2,498	1,884	2,203	2,544	2,752	2,030	2,181	2,225	2,896	2,293	2,395	2,409	3,029	2,282	4,061	2,719	2,824	2,177	2,908	2,404	2,862	2,464	2,489	3,076	3,813	3,256	3,243	3,146	3,663	4,003	3,512	3,949	4,164	3,208	3,729	15,050
Operating Income	2,527	2,485	2,591	2,698	2,439	2,245	2,726	2,832	2,323	2,382	2,472	2,678	2,476	2,048	2,355	2,323	2,453	2,008	2,129	828	2,378	2,304	2,500	2,176	2,660	2,230	1,921	2,684	2,021	1,271	991	1,909	2,047	2,311	1,178	2,644	2,526	3,942	2,666	3,514	12,648
Interest Expense	325	328	326	321	325	332	338	347	355	352	343	332	313	301	346	296	302	318	285	281	296	335	295	328	368	415	543	752	759	821	824	808	776	747	723	708	685	653	657	673	2,668
Pre-Tax Income	2,418	2,283	2,460	2,542	2,381	2,214	2,619	2,647	2,094	2,185	2,314	2,564	2,277	1,983	2,020	2,030	2,206	1,877	1,857	558	2,155	2,131	1,675	1,531	2,392	1,748	3,442	1,614	1,947	852	-68	794	3,101	782	1,973	1,568	3,921	1,514	2,084	2,768	10,287
Income Tax Expense	401	348	389	391	360	6,478	308	351	235	257	322	385	309	280	195	227	185	262	211	94	271	232	199	214	249	132	601	235	217	85	45	48	271	155	243	136	705	181	265	393	1,544
Net Income	2,017	1,935	2,071	2,151	2,021	-4,264	2,311	2,296	1,859	1,928	1,992	2,179	1,968	1,703	1,825	1,803	2,021	1,615	1,646	464	1,884	1,899	1,476	1,317	2,143	1,616	2,841	1,379	1,730	767	-113	746	2,830	627	1,730	1,432	3,216	1,333	1,819	2,375	8,743
EBITDA	3,246	3,170	3,310	3,381	3,170	2,995	3,428	3,478	2,950	3,027	3,152	3,397	3,098	2,986	3,263	3,256	3,409	3,068	2,983	1,694	3,301	3,318	2,811	2,687	3,597	3,074	4,885	3,262	3,601	3,053	2,155	3,002	5,273	2,926	4,083	3,617	5,913	3,299	3,857	3,441	16,510

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings